- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Profitable Climbers
Hong Kong Pharmaceuticals & Biotech Profitable Climbers
Results
11
11 companies
WuXi XDC Cayman
Market Cap: HK$71.8b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$56.15
7D
3.6%
1Y
26.2%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$37.9b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$53.80
7D
4.2%
1Y
252.6%
XtalPi Holdings
Market Cap: HK$39.1b
An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.
2228
HK$9.27
7D
-3.1%
1Y
55.3%
RemeGen
Market Cap: HK$65.1b
A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.
9995
HK$88.60
7D
-7.0%
1Y
298.2%
CanSino Biologics
Market Cap: HK$13.0b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$30.70
7D
-10.1%
1Y
-10.5%
Consun Pharmaceutical Group
Market Cap: HK$13.6b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$16.50
7D
0.7%
1Y
86.0%
JBM (Healthcare)
Market Cap: HK$2.2b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.69
7D
-0.7%
1Y
48.6%
Innovent Biologics
Market Cap: HK$143.2b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$79.40
7D
-3.0%
1Y
73.2%
Luye Pharma Group
Market Cap: HK$9.4b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$2.31
7D
-4.5%
1Y
-4.9%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$6.6b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$7.78
7D
-8.0%
1Y
-10.3%
China Medical System Holdings
Market Cap: HK$32.1b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$12.87
7D
-5.3%
1Y
66.1%